Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway ; volume:27 ; number:1 ; day:19 ; month:10 ; year:2021 ; pages:1-12 ; date:12.2021
Molecular medicine ; 27, Heft 1 (19.10.2021), 1-12, 12.2021
- Creator
-
Zeng, Jie
He, Si-Li
Li, Li-Jie
Wang, Chen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-021-00384-2
- URN
-
urn:nbn:de:101:1-2022011219045523356072
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zeng, Jie
- He, Si-Li
- Li, Li-Jie
- Wang, Chen
- SpringerLink (Online service)
Other Objects (12)
Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer
LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer
PP2Ac upregulates PI3K-Akt signaling and induces hepatocyte apoptosis in liver donor after brain death
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma
Buparlisib vermittelte PI3K-Inhibition moduliert die PD-L1 Expression im Kopf-Hals-Plattenepithelkarzinom
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer
LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer
PP2Ac upregulates PI3K-Akt signaling and induces hepatocyte apoptosis in liver donor after brain death
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma
Buparlisib vermittelte PI3K-Inhibition moduliert die PD-L1 Expression im Kopf-Hals-Plattenepithelkarzinom
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer
LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer
PP2Ac upregulates PI3K-Akt signaling and induces hepatocyte apoptosis in liver donor after brain death
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma
Buparlisib vermittelte PI3K-Inhibition moduliert die PD-L1 Expression im Kopf-Hals-Plattenepithelkarzinom